V. Gorbounova

663 total citations · 1 hit paper
7 papers, 516 citations indexed

About

V. Gorbounova is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, V. Gorbounova has authored 7 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in V. Gorbounova's work include Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Brain Metastases and Treatment (2 papers). V. Gorbounova is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Brain Metastases and Treatment (2 papers). V. Gorbounova collaborates with scholars based in Russia, Germany and Poland. V. Gorbounova's co-authors include Joachim von Pawel, Rodryg Ramlau, C. Manegold, Norman C. Moore, Martin Reck, Venice Archer, Petr Zatloukal, N. B. Leighl, J. Mezger and Vera Hirsh and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

V. Gorbounova

5 papers receiving 501 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

2010 498 citations Martin Reck, Joachim von Pawel et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Gorbounova Russia	3	397	359	124	95	46	7	516
Jin‐Ji Yang China	13	458 1.2×	316 0.9×	138 1.1×	120 1.3×	44 1.0×	83	574
Rinat Galiulin United States	6	388 1.0×	370 1.0×	135 1.1×	110 1.2×	39 0.8×	7	556
Eric D. Mininberg United States	3	307 0.8×	345 1.0×	192 1.5×	96 1.0×	39 0.8×	6	494
H. Doubre France	12	524 1.3×	372 1.0×	113 0.9×	81 0.9×	62 1.3×	33	629
N. B. Leighl United States	11	568 1.4×	498 1.4×	206 1.7×	128 1.3×	67 1.5×	32	758
Johann Raats South Africa	9	280 0.7×	367 1.0×	188 1.5×	83 0.9×	101 2.2×	15	569
See‐Chun Phan United States	11	249 0.6×	303 0.8×	89 0.7×	65 0.7×	45 1.0×	17	435
Bente Frimodt‐Moller United States	10	549 1.4×	527 1.5×	164 1.3×	166 1.7×	37 0.8×	24	766
Penelope Ann Bradbury Canada	9	304 0.8×	227 0.6×	87 0.7×	116 1.2×	29 0.6×	39	375
Peter Schirmacher Germany	9	265 0.7×	239 0.7×	143 1.2×	189 2.0×	32 0.7×	17	470

Countries citing papers authored by V. Gorbounova

Since Specialization

Citations

This map shows the geographic impact of V. Gorbounova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Gorbounova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Gorbounova more than expected).

Fields of papers citing papers by V. Gorbounova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Gorbounova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Gorbounova. The network helps show where V. Gorbounova may publish in the future.

Co-authorship network of co-authors of V. Gorbounova

This figure shows the co-authorship network connecting the top 25 collaborators of V. Gorbounova. A scholar is included among the top collaborators of V. Gorbounova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Gorbounova. V. Gorbounova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gorbounova, V., et al.. (2012). Long Acting Octreotide in PTS with Disseminated Neuroendocrine Tumors. Annals of Oncology. 23. ix382–ix382. 2 indexed citations

2.

Gorbounova, V., et al.. (2012). Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIS) Erlotinib and Gefitinib in the Treatment of Patients with Brain Metastases from Non-Small Cell Lung Cancer (NSCLC). Annals of Oncology. 23. ix435–ix435.

3.

Reck, Martin, Joachim von Pawel, Petr Zatloukal, et al.. (2010). Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Annals of Oncology. 21(9). 1804–1809. 498 indexed citations breakdown →

4.

Gorbounova, V., et al.. (2009). Capecitabine monotherapy for patients with brain metastases from advanced breast cancer. Journal of Clinical Oncology. 27(15_suppl). 1102–1102. 3 indexed citations

5.

Belani, Chandra P., Joachim von Pawel, A Płużańska, et al.. (2005). P-452 Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender. Lung Cancer. 49. S235–S235. 11 indexed citations

6.

Wimberger, Pauline, Alexander Burges, V. Gorbounova, et al.. (2004). Tolerability and efficacy of the trifunctional antibody removab® (anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study. Cancer Cell International. 4(S1). 1 indexed citations

7.

Gorbounova, V., et al.. (1998). The increasing of effect after discontinuation of the treatment with Taxotere in patients with breast cancer. European Journal of Cancer. 34. S21–S21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact